We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01474954
Recruitment Status : Terminated (Low enrollment)
First Posted : November 18, 2011
Last Update Posted : May 12, 2015
Tobira Therapeutics, Inc.
Information provided by (Responsible Party):
University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : December 2012
  Study Completion Date : December 2012